소화관 스텐트 시장 보고서 : 제품 유형, 기술 유형, 재료, 최종 사용자, 지역별(2025-2033년)

The global gastrointestinal stents market size reached USD 446.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 579.0 Million by 2033, exhibiting a growth rate (CAGR) of 2.9% during 2025-2033.

A gastrointestinal stent refers to an artificial tube graft that is inserted in the body to prevent blockages in the gullet, stomach and small intestine. It is an expandable metal or a plastic mesh tube that is placed in an anatomical duct, such as bile ducts, esophagus, bowel or colon, and blockages due to cancerous tissues. It aims to remove the obstruction and reduce the pressure caused by inflammation. Some of the most common types of gastrointestinal stents include biliary, colonic, duodenal, esophageal and pancreatic stents.

The rising prevalence of colorectal cancer across the globe is one of the key factors driving the growth of the market. Furthermore, an increasing geriatric population suffering from gastrointestinal diseases, such as bowel ailments, diverticulosis and gastrointestinal malignancies, is also providing a boost to the market growth. Additionally, the growing preference for minimally invasive (MI) surgical procedures, along with the rising health consciousness among the masses, is creating a significant impact on the market. In comparison to the traditional open surgery procedures, gastrointestinal stenting involves low risk of infections, minimal loss of blood and quick recuperation period. Moreover, various technological advancements, including the development of bio-absorbable and nitinol material-based stents offering a high degree of flexibility and kink-resistance, is acting as another growth-inducing factor. Other factors, including significant growth in the healthcare infrastructure, the implementation of favourable government policies and extensive research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:

Breakup by Product Type:

• Biliary Stents
• Duodenal Stents
• Colonic Stents
• Pancreatic Stents
• Esophageal Stents

Breakup by Technology Type:

• Anti-Migratory Stents
• Drug-Eluting Stents
• Radioactive Stents
• Anti-Reflux Stents
• Shape-Modified Stents
• Others

Breakup by Material:

• Plastic Stents
• Self-Expanding Metal Stents
• Stainless Steel Stents
• Nitinol Stents
• Others
• Covered Self-Expandable Metallic Stents
• Biodegradable or Drug Eluting Stents

Breakup by End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centres
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Becton, Dickinson and Company, Boston Scientific Corporation, Cantel Medical Corporation, Conmed Corporation, Cook Group Incorporated, ELLA-CS, S.R.O., Hobbs Medical Inc., Merit Medical Systems Inc., Olympus Corporation, Taewoong Medical Co. Ltd., etc.

Key Questions Answered in This Report

• 1.What was the size of the global gastrointestinal stents market in 2024?
• 2.What is the expected growth rate of the global gastrointestinal stents market during 2025-2033?
• 3.What are the key factors driving the global gastrointestinal stents market?
• 4.What has been the impact of COVID-19 on the global gastrointestinal stents market?
• 5.What is the breakup of the global gastrointestinal stents market based on the product type?
• 6.What is the breakup of the global gastrointestinal stents market based on technology type?
• 7.What is the breakup of the global gastrointestinal stents market based on the material?
• 8.What is the breakup of the global gastrointestinal stents market based on the end user?
• 9.What are the key regions in the global gastrointestinal stents market?
• 10.Who are the key players/companies in the global gastrointestinal stents market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Gastrointestinal Stents Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Biliary Stents
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Duodenal Stents
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Colonic Stents
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Pancreatic Stents
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Esophageal Stents
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Technology Type

• 7.1 Anti-Migratory Stents
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Drug-Eluting Stents
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Radioactive Stents
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Anti-Reflux Stents
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Shape-Modified Stents
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Material

• 8.1 Plastic Stents
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Self-Expanding Metal Stents
  • 8.2.1 Market Trends
  • 8.2.2 Major Types
    • 8.2.2.1 Stainless Steel Stents
    • 8.2.2.2 Nitinol Stents
    • 8.2.2.3 Others
  • 8.2.3 Market Forecast
• 8.3 Covered Self-Expandable Metallic Stents
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Biodegradable or Drug Eluting Stents
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Specialty Clinics
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Ambulatory Surgical Centres
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Becton, Dickinson and Company
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Boston Scientific Corporation
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Cantel Medical Corporation
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Conmed Corporation
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Cook Group Incorporated
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 ELLA-CS, S.R.O.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Hobbs Medical Inc.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Merit Medical Systems Inc.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Olympus Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Taewoong Medical Co, Ltd.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio